ArticleBMC plant biology2026
A comprehensive analysis of the potential of two closely related species from the genus Codonopsis as supplementary sources for Codonopsis radix based on metabolomics.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Codonopsis Radix (CR) is a widely used canonical medicinal and edible herb. Its official botanical sources, including C. pilosula (CP), C. pilosula var. modesta (CPM), and C. tangshen (CTS), are geographically constrained. This limited distribution has led to the use of local alternatives, such as C. lanceolata (CL) and C. tubulosa (CT). The scientific basis for substituting these alternatives remains unvalidated. In this study, untargeted metabolomics, network pharmacology, and quantitative analysis were integrated to assess metabolic similarity and identify distinctive bioactive components. Our results demonstrated a conserved core metabolome, with over 90% similarity in metabolite types and 18 shared core active compounds, suggesting a common basis for their traditional medicinal use. Notably, CT exhibited the highest polysaccharide content, and CL was significantly enriched in amino acids. This study not only provides metabolic evidence to support the use of CL and CT as qualified potential supplementary resources for CR but also proposes a dual-track strategy: their core metabolic conservation forms a solid foundation for their potential use as substitutes, while their specialized metabolite enrichment opens avenues for developing targeted functional foods and regionally distinct medicinal products.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.